Shares BioMimetic Therapeutics, Inc. Common Stock ($0.001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2007 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), Samuel Lynch (“Selling Stockholder A”) and [____] (the “Other Selling Stockholders” and together with Selling Stockholder A, the “Selling Stockholders”) propose to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of [___] shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”) of which [___] shares will be sold by the Company and [__] shares will be sold by the Selling Stockholders. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto and the respective amounts to be sold by the Selling Stockholders are set forth opposite their names on Schedule II. The Company and the Selling Stockholders are sometimes referred to herein collectively as the “Sellers”. The Company [and the Sel
